Vonoprazan-Based Dual and Quadruple Therapy with Varying Duration for Helicobacter pylori Eradication: A Multicenter, Randomized Controlled Trial

International Journal of Antimicrobial Agents · Published 2026-08-01 · DOI 10.1016/j.ijantimicag.2026.107948

Authors (20)

Kunping Ju, Hanyue Zhao, Leina Guo, Zhenzhen Zhai, Xiaohui Song, Hongyu Zhao, Weiwei Zhang, Xiaowei Li, Huijuan Zhang, Wei Xia, Ruiqi Zheng, Shangshang Liu, Longfei Sun, Ruihao Ding, Xuyan Liu, Teng Teng, Qingzhou Kong, Yueyue Li, Xiuli Zuo, Yanqing Li

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ju, K., Zhao, H., Guo, L., et al. (2026). Vonoprazan-Based Dual and Quadruple Therapy with Varying Duration for Helicobacter pylori Eradication: A Multicenter, Randomized Controlled Trial. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2026.107948

Related articles

• Tailored Therapy Guided by Antibiotic Genotypic Resistances and CYP2C19 Polymorphisms Detected From Fecal Specimens for the First‐Line Helicobacter pylori Eradication: A Randomized Controlled Trial · Helicobacter · 2025 · Cites or is cited by this article
• Ten‐Day Versus 14‐Day Vonoprazan and Amoxicillin Dual Therapy for the Firstline Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial · Helicobacter · 2025 · Cites or is cited by this article
• Machine learning-based drug susceptibility prediction from Candida genomic data · International Journal of Antimicrobial Agents · 2026 · Same journal
• Emergence of dalbavancin non-susceptible methicillin-resistant Staphylococcus epidermidis (MRSE) in a patient treated with dalbavancin prolonged therapy: Case report, therapeutic drug monitoring and genomic characterization · International Journal of Antimicrobial Agents · 2026 · Same journal
• Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacterales bacteraemia in high-risk neutropenic patients in haematology: A multicentre retrospective study · International Journal of Antimicrobial Agents · 2026 · Same journal
• An exploratory pharmacokinetic-pharmacodynamic analysis of ceftazidime-avibactam and various blood biomarkers in patients with hospital-acquired pneumonia or ventilator-associated pneumonia caused by Klebsiella pneumoniae · International Journal of Antimicrobial Agents · 2026 · Same journal
• Vancomycin penetration into intra-abdominal compartments: Site concentration disparities and implications for dose optimization in gram-positive infections · International Journal of Antimicrobial Agents · 2026 · Same journal
• Optimizing the Meropenem Dosing Regimen in Neonates: A Dual-Centre Cohort Study · International Journal of Antimicrobial Agents · 2026 · Same journal
• A Novel blaTMB Allele Encoding a Functional Carbapenemase Associated with a Gamma-Mobile-Trio Island · International Journal of Antimicrobial Agents · 2026 · Same journal
• Ecr positively regulates activity of the PhoQ/PhoP signalling system in Klebsiella pneumoniae · International Journal of Antimicrobial Agents · 2026 · Same journal